Results 141 to 150 of about 4,708 (180)

Cisplatin-induced ototoxicity: the current state of ototoxicity monitoring in New Zealand. [PDF]

, 2011
Background: Many well-known pharmacologic agents have been shown to have toxic effects to the cochleo-vestibular system. Examples of such ototoxic agents include cisplatin and aminoglycoside antibiotics. Ototoxicity monitoring consists of a comprehensive pattern of audiological assessments designed to detect the onset of any hearing loss.
Venter, Kinau
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Trends in ototoxicity monitoring among cisplatin-treated patients with cancer

Journal of Cancer Survivorship
This study aims to characterize patterns in ototoxicity monitoring and identify potential barriers to audiologic follow-up.We performed a single-institution retrospective cohort study on adult (≥ 18 years old) cancer patients treated with cisplatin from January 2014 to September 2021.
David S Lee, Thorstad Wade L, Zevallos JOSÉ P   +2 more
exaly   +3 more sources

Ototoxicity Monitoring: Program Approaches and Considerations

Seminars in Hearing, 2011
Dawn Konrad-Martin, Wendy J Helt, Marilyn F Dille   +2 more
exaly   +2 more sources

Vestibular Ototoxicity: The Importance and Pragmatics of Monitoring

Seminars in Hearing, 2011
exaly   +2 more sources

Audiologic Monitoring for Ototoxicity

Otolaryngologic Clinics of North America, 1993
In summary, the clinician has a variety of protocols available for monitoring ototoxicity. Depending on the patient's risk factors and ability to be tested, the protocol for a given patient may vary. A flow chart reflecting some of the possible decisions and options is presented in Figure 1.
K C, Campbell, J, Durrant
openaire   +2 more sources

The use of tele-audiology in ototoxicity monitoring: A scoping review

Journal of Telemedicine and Telecare, 2022
Introduction Due to the growing burden of disease in South Africa, encompassing conditions such as tuberculosis, human immunodeficiency virus, and cancer, the holistic management of affected patients incorporating ototoxicity monitoring is a necessity.
Nazeera Peerbhay, Danielle R Munsamy, Hombisa P Dlamini, Fisokuhle Langa, Jessica Paken   +4 more
openaire   +2 more sources

Audiometric monitoring of cis-platinum ototoxicity

Gynecologic Oncology, 1983
A prospective study was performed on 37 patients receiving 50 mg/m2 of cis-platinum every 3 to 4 weeks. These patients received a baseline audiogram evaluation and subsequent testing before each dose. Ototoxicity was noted to occur in 46% of the patients during therapy. Fourteen percent of this group showed a hearing loss in the speech frequency range.
R L, Brown, R C, Nuss, R, Patterson, J, Irey   +3 more
openaire   +2 more sources

Drug-Induced Ototoxicity: Diagnosis and Monitoring

Drug Safety, 2018
Ototoxicity diagnosis and management has historically been approached using a variety of methods. However, in recent years a consensus on useful and practical approaches has been developed through clinical guidelines of the American Speech Language Hearing Association, the American Academy of Audiology, and multiple clinical trials published in peer ...
Kathleen C M, Campbell, Colleen G, Le Prell   +1 more
openaire   +2 more sources

Challenges in Ototoxicity Monitoring in the Pediatric Oncology Population

Journal of the American Academy of Audiology, 2014
Background:Platinum-based chemotherapy and cranial radiation are effective treatment options commonly prescribed for a variety of childhood cancers. These therapies can, and often do, result in early- and late-onset adverse health effects such as hearing loss.
Johnnie K, Bass, Shaum P, Bhagat
openaire   +2 more sources

Current practice of ototoxicity management across the United Kingdom (UK) [PDF]

International Journal of Audiology, 2018
OBJECTIVE: Effective management of patients diagnosed with ototoxicity is needed to reduce hearing and balance damage which affects communication and life quality.
Ghada Al-Malky
exaly   +1 more source